• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

橙皮苷-环糊精-壳聚糖三元复合物的配方:理化特性、体外和体内研究。

Formulation of Apigenin-Cyclodextrin-Chitosan Ternary Complex: Physicochemical Characterization, In Vitro and In Vivo Studies.

机构信息

Department of Pharmaceutics, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam, 34212, Saudi Arabia.

Department of Pharmacology, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, P.O. Box 1982, Dammam, 34212, Saudi Arabia.

出版信息

AAPS PharmSciTech. 2022 Feb 10;23(2):71. doi: 10.1208/s12249-022-02218-8.

DOI:10.1208/s12249-022-02218-8
PMID:35146576
Abstract

The current investigation was performed with an aim to improve the aqueous solubility, dissolution rate, and thus the biological activity of apigenin (APG) using the solubilizers hydroxypropyl beta-cyclodextrin (HPβCD) and chitosan (CTSN). A binary and ternary inclusion complexes of APG with HPβCD and CTSN were prepared by physical mixing, fusion, and solvent evaporation methods. The liquid state characterization of the APG, the solubilizers, and the physical and chemical interactions between them was done through phase solubility approach. The solid-state characterization was performed by proton nuclear magnetic resonance (1H-NMR), differential scanning calorimetry (DSC), and X-ray diffractometry (XRD). The in vitro dissolution test and antioxidant activity and in vivo anti-inflammatory activity of the ternary inclusion complex in albino rats were performed to assess the performance of the APG. Phase solubility study results revealed a remarkable increase in apparent stability constant (Kc) and complexation efficiency (CE) of HPβCD in presence of CTSN in ternary complex with above 8 folds more increment in solubility of APG than its binary complex. The in vitro dissolution rate, antioxidant activity, and the anti-inflammatory effect of the APG ternary inclusion complex were found to be significantly higher than that of pure APG. Solid state characterization confirmed the formation of a ternary inclusion complex. 1H-NMR study gave more insight at molecular level into how different groups of APG were responsible for complex formation with the HPβCD and how CTSN was significantly influencing on the APG-HPβCD complex formed. Nevertheless, pharmacokinetic and histopathological studies of our APG-HPβCD-CTSN ternary complex would yield much rewarding results.

摘要

本研究旨在通过使用增溶剂羟丙基-β-环糊精(HPβCD)和壳聚糖(CTSN)来提高芹菜素(APG)的水溶性、溶解速率,进而提高其生物活性。通过物理混合、熔融和溶剂蒸发法制备了 APG 与 HPβCD 和 CTSN 的二元和三元包合物。通过相溶解度法对 APG、增溶剂及其之间的物理化学相互作用进行了液态特征描述。通过质子核磁共振(1H-NMR)、差示扫描量热法(DSC)和 X 射线衍射法(XRD)进行了固态特征描述。在白化大鼠中进行了三元包合物的体外溶解试验、抗氧化活性和体内抗炎活性研究,以评估 APG 的性能。相溶解度研究结果表明,在三元复合物中存在 CTSN 时,HPβCD 的表观稳定常数(Kc)和络合效率(CE)显著增加,APG 的溶解度比二元复合物增加了 8 倍以上。APG 三元包合物的体外溶解速率、抗氧化活性和抗炎作用明显高于纯 APG。固态特征描述证实了三元包合物的形成。1H-NMR 研究在分子水平上进一步证实了 APG 的不同基团如何与 HPβCD 形成络合物,以及 CTSN 如何显著影响形成的 APG-HPβCD 络合物。然而,我们的 APG-HPβCD-CTSN 三元复合物的药代动力学和组织病理学研究将产生更有价值的结果。

相似文献

1
Formulation of Apigenin-Cyclodextrin-Chitosan Ternary Complex: Physicochemical Characterization, In Vitro and In Vivo Studies.橙皮苷-环糊精-壳聚糖三元复合物的配方:理化特性、体外和体内研究。
AAPS PharmSciTech. 2022 Feb 10;23(2):71. doi: 10.1208/s12249-022-02218-8.
2
Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.依托度酸与羟丙基-β-环糊精及辅助剂的包合作用:制剂表征与分子模拟研究
Mol Pharm. 2017 Apr 3;14(4):1231-1242. doi: 10.1021/acs.molpharmaceut.6b01115. Epub 2017 Mar 1.
3
Characterization of an inclusion complex of cholesterol and hydroxypropyl-beta-cyclodextrin.胆固醇与羟丙基-β-环糊精包合物的表征
Eur J Pharm Biopharm. 1998 Nov;46(3):355-60. doi: 10.1016/s0939-6411(98)00033-2.
4
Influence of levodropropizine and hydroxypropyl-β-cyclodextrin association on the physicochemical characteristics of levodropropizine loaded in hydroxypropyl-β-cyclodextrin microcontainers: Formulation and in vitro characterization.左羟丙哌嗪与羟丙基-β-环糊精缔合对负载于羟丙基-β-环糊精微容器中的左羟丙哌嗪理化特性的影响:制剂与体外特性研究
Polim Med. 2019 Jan-Jun;49(1):35-43. doi: 10.17219/pim/111887.
5
The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-beta-cyclodextrin.聚乙烯吡咯烷酮对萘普生与羟丙基-β-环糊精络合的影响。
Eur J Pharm Sci. 2001 May;13(2):187-94. doi: 10.1016/s0928-0987(01)00093-8.
6
Complexation of the interferon inducer, bropirimine, with hydroxypropyl-beta-cyclodextrin.干扰素诱导剂溴匹立明与羟丙基-β-环糊精的络合作用
Eur J Pharm Sci. 2000 Feb;9(4):381-6. doi: 10.1016/s0928-0987(99)00081-0.
7
Enhanced Solubility and Stability of Aripiprazole in Binary and Ternary Inclusion Complexes Using Hydroxy Propyl Beta Cyclodextrin (HPβCD) and L-Arginine.使用羟丙基-β-环糊精(HPβCD)和 L-精氨酸提高阿立哌唑在二元和三元包合物中的溶解度和稳定性。
Molecules. 2023 May 3;28(9):3860. doi: 10.3390/molecules28093860.
8
Preparation and comparison of binary and ternary inclusion complexes of aripiprazole using L-arginine/lysine and MβCD/HPβCD by using different molar ratios.采用不同摩尔比的 L-精氨酸/赖氨酸和 MβCD/HPβCD 制备和比较阿立哌唑的二元和三元包合物。
Pak J Pharm Sci. 2024 Jan;37(1(Special)):245-255.
9
Binary and ternary inclusion complexes of finasteride in HPbetaCD and polymers: preparation and characterization.非那雄胺在羟丙基-β-环糊精及聚合物中的二元和三元包合物:制备与表征
Bioorg Med Chem. 2009 Apr 1;17(7):2718-23. doi: 10.1016/j.bmc.2009.02.044. Epub 2009 Feb 26.
10
Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.1,2 - 二硫杂环戊烯 - 3 - 硫酮与β - 环糊精及其羟丙基和磺丁基醚 - 7衍生物络合后溶解度和溶解速率的提高。
J Pharm Sci. 1999 Sep;88(9):889-95. doi: 10.1021/js990067o.

引用本文的文献

1
Development of Vaginal In Situ Gel Containing ISN/HP-β-CD Inclusion Complex for Enhanced Solubility and Antifungal Efficacy.含异山梨醇/羟丙基-β-环糊精包合物的阴道原位凝胶的研制,以提高溶解度和抗真菌疗效。
Polymers (Basel). 2025 Feb 16;17(4):514. doi: 10.3390/polym17040514.
2
High-throughput screening identification of apigenin that reverses the colistin resistance of mcr-1-positive pathogens.高通量筛选鉴定芹菜素逆转 mcr-1 阳性病原体对黏菌素耐药性。
Microbiol Spectr. 2024 Oct 3;12(10):e0034124. doi: 10.1128/spectrum.00341-24. Epub 2024 Sep 9.
3
Neuroprotective effects of apigenin on retinal ganglion cells in ischemia/reperfusion: modulating mitochondrial dynamics in in vivo and in vitro models.

本文引用的文献

1
Ethanol-assisted kneading of apigenin with arginine for enhanced dissolution rate of apigenin: development of rapidly disintegrating tablets.乙醇辅助槲皮素与精氨酸揉捏提高槲皮素溶出速率:速崩片的研制。
Pharm Dev Technol. 2021 Jul;26(6):693-700. doi: 10.1080/10837450.2021.1922441. Epub 2021 May 6.
2
Enhancement in corneal permeability of riboflavin using cyclodextrin derivates complexes as a previous step to transepithelial cross-linking.使用环糊精衍生物复合物作为跨上皮交联的前序步骤,增强核黄素的角膜通透性。
Eur J Pharm Biopharm. 2021 May;162:12-22. doi: 10.1016/j.ejpb.2021.02.012. Epub 2021 Mar 2.
3
Formulation of Curcumin-β-cyclodextrin-polyvinylpyrrolidone supramolecular inclusion complex: experimental, molecular docking, and preclinical anti-inflammatory assessment.
芹菜素对缺血/再灌注视网膜神经节细胞的神经保护作用:在体内和体外模型中调节线粒体动力学。
J Transl Med. 2024 May 13;22(1):447. doi: 10.1186/s12967-024-05260-1.
4
Enhanced oral delivery of hesperidin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for augmenting its hypoglycemic activity: in vitro-in vivo assessment study.载有橙皮苷的磺丁基醚-β-环糊精/壳聚糖纳米粒增强口服给药以增强其降血糖活性:体内外评估研究
Drug Deliv Transl Res. 2024 Apr;14(4):895-917. doi: 10.1007/s13346-023-01440-6. Epub 2023 Oct 16.
5
Development of A Nanostructured Lipid Carrier-Based Drug Delivery Strategy for Apigenin: Experimental Design Based on CCD-RSM and Evaluation against NSCLC In Vitro.基于纳米结构脂质载体的芹菜素给药策略的开发:基于 CCD-RSM 的实验设计及对 NSCLC 的体外评价。
Molecules. 2023 Sep 17;28(18):6668. doi: 10.3390/molecules28186668.
6
Preparation and In Vitro and In Vivo Evaluation of Rectal In Situ Gel of Meloxicam Hydroxypropyl-β-cyclodextrin Inclusion Complex.美洛昔康羟丙基-β-环糊精包合物直肠原位凝胶的制备及体外和体内评价。
Molecules. 2023 May 15;28(10):4099. doi: 10.3390/molecules28104099.
7
Improvement in Solubility-Permeability Interplay of Psoralens from Plant Extract upon Complexation with Hydroxypropyl-β-cyclodextrin.植物提取物中补骨脂素的溶解度-渗透性相互作用经羟丙基-β-环糊精包合后的改善。
Molecules. 2022 Jul 19;27(14):4580. doi: 10.3390/molecules27144580.
姜黄素-β-环糊精-聚乙烯吡咯烷酮超分子包合物的制备:实验、分子对接及临床前抗炎评估
Drug Dev Ind Pharm. 2020 Sep;46(9):1524-1534. doi: 10.1080/03639045.2020.1810268. Epub 2020 Aug 27.
4
Formation of inclusion complex of enrofloxacin with 2-hydroxypropyl--cyclodextrin.恩诺沙星与 2-羟丙基-β-环糊精包合物的形成。
Drug Deliv. 2020 Dec;27(1):334-343. doi: 10.1080/10717544.2020.1724210.
5
Enhanced Solubility and Bioavailability of Apigenin via Preparation of Solid Dispersions of Mesoporous Silica Nanoparticles.通过制备介孔二氧化硅纳米颗粒固体分散体提高芹菜素的溶解度和生物利用度
Iran J Pharm Res. 2019 Winter;18(1):168-182.
6
Simultaneously Improving the Physicochemical Properties, Dissolution Performance, and Bioavailability of Apigenin and Daidzein by Co-Crystallization With Theophylline.通过与茶碱共结晶同时改善芹菜素和大豆苷元的理化性质、溶解性能和生物利用度。
J Pharm Sci. 2019 Sep;108(9):2982-2993. doi: 10.1016/j.xphs.2019.04.017. Epub 2019 Apr 25.
7
Dissolution and bioavailability improvement of bioactive apigenin using solid dispersions prepared by different techniques.使用不同技术制备的固体分散体改善生物活性芹菜素的溶出度和生物利用度
Saudi Pharm J. 2019 Feb;27(2):264-273. doi: 10.1016/j.jsps.2018.11.008. Epub 2018 Nov 14.
8
Dose- and time-dependent pharmacokinetics of apigenin trimethyl ether.柚皮素三甲醚的剂量和时间依赖性药代动力学。
Eur J Pharm Sci. 2018 Jun 15;118:96-102. doi: 10.1016/j.ejps.2018.03.022. Epub 2018 Mar 21.
9
Apigenin: A dietary flavonoid with diverse anticancer properties.芹菜素:一种具有多种抗癌特性的膳食类黄酮。
Cancer Lett. 2018 Jan 28;413:11-22. doi: 10.1016/j.canlet.2017.10.041. Epub 2017 Oct 31.
10
Solubility and dissolution rate improvement of the inclusion complex of apigenin with 2-hydroxypropyl-β-cyclodextrin prepared using the liquid antisolvent precipitation and solvent removal combination methods.采用液体反溶剂沉淀法和溶剂去除联合法制备的芹菜素与2-羟丙基-β-环糊精包合物的溶解度和溶解速率提高
Drug Dev Ind Pharm. 2017 Aug;43(8):1366-1377. doi: 10.1080/03639045.2017.1318900. Epub 2017 Apr 24.